Filing Details

Accession Number:
0000899243-22-006626
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-16 16:05:22
Reporting Period:
2022-02-15
Accepted Time:
2022-02-16 16:05:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1537917 Tyme Technologies Inc. TYME Pharmaceutical Preparations (2834) 453864597
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1710484 James Biehl C/O Tyme Technologies, Inc.
1 Pluckemin Way - Suite 103
Bedminster NJ 07921
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-15 20,000 $0.34 105,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 150 Indirect See footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3345 to $0.3363, inclusive, on February 15, 2022.
  2. 150 shares are owned by Mr. Biehl's spouse.